342 related articles for article (PubMed ID: 37171239)
1. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
Nadolsky K; Cryer DR; Articolo A; Fisher T; Schneider J; Rinella M
Ann Med; 2023 Dec; 55(1):2211349. PubMed ID: 37171239
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
Shelley K; Articolo A; Luthra R; Charlton M
BMC Gastroenterol; 2023 May; 23(1):160. PubMed ID: 37208593
[TBL] [Abstract][Full Text] [Related]
3. Medical journey of patients with polycystic ovary syndrome and obesity: a cross-sectional survey of patients and primary care physicians.
Sherif K; Coborn J; Hoovler A; Gill L
Postgrad Med; 2023 Apr; 135(3):312-320. PubMed ID: 36330844
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey.
Rinella M; Cryer DR; Articolo A; Fisher T; Schneider J; Nadolsky K
BMC Gastroenterol; 2022 Jul; 22(1):335. PubMed ID: 35811319
[TBL] [Abstract][Full Text] [Related]
5. Engagement between patients with obesity and osteoarthritis and primary care physicians: a cross-sectional survey.
Horn DB; Damsgaard C; Earles K; Mathew S; Nelson AE
Postgrad Med; 2021 Nov; 133(8):979-987. PubMed ID: 34538196
[TBL] [Abstract][Full Text] [Related]
6. Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.
Brunton S; Pruzin JJ; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
Postgrad Med; 2023 Jun; 135(5):530-538. PubMed ID: 37219410
[TBL] [Abstract][Full Text] [Related]
7. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?
Wessels DH; Rosenberg Z
World J Hepatol; 2021 Feb; 13(2):233-241. PubMed ID: 33708352
[TBL] [Abstract][Full Text] [Related]
8. A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH survey.
Driessen S; de Jong VD; van Son KC; Klompenhouwer T; Colardelle Y; Alings M; Moreno C; Anker SD; Castro Cabezas M; Holleboom AG; Grobbee DE; Tushuizen ME
United European Gastroenterol J; 2023 Sep; 11(7):654-662. PubMed ID: 37563849
[TBL] [Abstract][Full Text] [Related]
9. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
Polanco-Briceno S; Glass D; Stuntz M; Caze A
BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease from a primary care perspective.
Clark JM; Cryer DRH; Morton M; Shubrook JH
Diabetes Obes Metab; 2023 Jun; 25(6):1421-1433. PubMed ID: 36789676
[TBL] [Abstract][Full Text] [Related]
11. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions.
Anstee QM; Hallsworth K; Lynch N; Hauvespre A; Mansour E; Kozma S; Marino JP; Bottomley J; Piercy J; Higgins V
JHEP Rep; 2022 Jan; 4(1):100411. PubMed ID: 34977520
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Steatohepatitis: A Review.
Sheka AC; Adeyi O; Thompson J; Hameed B; Crawford PA; Ikramuddin S
JAMA; 2020 Mar; 323(12):1175-1183. PubMed ID: 32207804
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.
Pattison RJ; Esteban JP; Sempokuya T; Kewcharoen J; Kalathil S; Kuwada SK
Hawaii J Health Soc Welf; 2020 Jun; 79(6):180-186. PubMed ID: 32524096
[TBL] [Abstract][Full Text] [Related]
14. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
Kim SK; Kim KI; Kim SR
Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
[TBL] [Abstract][Full Text] [Related]
15. Management of patients with non-alcoholic steatohepatitis (NASH) in real life.
Serfaty L
Liver Int; 2018 Feb; 38 Suppl 1():52-55. PubMed ID: 29427486
[TBL] [Abstract][Full Text] [Related]
16. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management.
Gracious BL; Bhatt R; Potter C
J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):602-10. PubMed ID: 26447642
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
Roeb E; Geier A
Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database.
Terai S; Buchanan-Hughes A; Ng A; Lee IH; Hasegawa K
J Gastroenterol; 2021 Mar; 56(3):274-284. PubMed ID: 33496858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
